LATEST ANALYSIS
January 13, 2011
Pharma Watch: Protalix Rings in 2011 With $150 Million Offering
By Jack Bunker
In what may be a biotech harbinger for 2011, Israel’s Protalix Biotherapeutics will offer $150 million in stock under an existing shelf prospectus…
|
|
|
|
If you already have a OnePass account, you can use it to access Business Law Currents as part of our free trial
program. If you don’t have a OnePass account, click on the link to the left to create one. You can then use this
OnePass account to access Business Law Currents as part of our free trial.
|
|